Stoic VC logo

Stoic VC

Oceania, New South Wales, Australia, Sydney

Description

Stoic Venture Capital is an early-stage venture fund investing in emerging science and deep technology.

Investor Profile

Stoic VC has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series Unknown (33%)
  • Series B (33%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stoic VC frequently co-invest with?

HESTA
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Uniseed
Oceania, Queensland, Australia, Brisbane
Co-Investments: 3
AustralianSuper
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Statewide Super
Oceania, South Australia, Australia, Adelaide
Co-Investments: 1
Minderoo Foundation
Oceania, Western Australia, Australia, Perth
Co-Investments: 1
UC
North America, Michigan, United States, Northville
Co-Investments: 1
CSL
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Hostplus
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Brandon Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 2

Which angels does Stoic VC often collaborate with?

RT
North America, Pennsylvania, United States
Shared Deals: 1

What are some of recent deals done by Stoic VC?

Kinoxis Therapeutics

Melbourne, Victoria, Australia

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

BiotechnologyTherapeutics
Series BAug 12, 2024
Amount Raised: $9,548,268
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series UnknownJun 17, 2021
Amount Raised: $24,181,549
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series ASep 28, 2020
Amount Raised: $8,299,573